Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stomach relief for myasthenia gravis patients? study stopped early

NCT ID NCT04226170

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 23 times

Summary

This study tested whether adding ondansetron could reduce nausea, vomiting, or diarrhea caused by pyridostigmine in people with myasthenia gravis. Only 2 participants were enrolled before the study was terminated. The goal was to improve quality of life by managing treatment side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

Conditions

Explore the condition pages connected to this study.